Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
32.41
+4.20 (14.89%)
May 20, 2026, 4:00 PM EDT - Market closed
Roivant Sciences Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Roivant Sciences stock has a consensus rating of "Strong Buy" and an average price target of $37.04. The average 1-year stock price forecast is 14.29% higher than the current stock price, while the lowest is $29.5 (-8.98%) and the highest is $45 (+38.85%).
Price Target: $37.04 (+14.29%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 16, 2026.
Analyst Ratings
The average analyst rating for Roivant Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $22 → $40 | Buy | Maintains | $22 → $40 | +23.42% | Apr 16, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $33 → $34 | Strong Buy | Maintains | $33 → $34 | +4.91% | Mar 4, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $26 → $35 | Strong Buy | Maintains | $26 → $35 | +7.99% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $26 → $33 | Strong Buy | Maintains | $26 → $33 | +1.82% | Feb 10, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $28 → $30 | Strong Buy | Maintains | $28 → $30 | -7.44% | Feb 9, 2026 |
Financial Forecast
Revenue This Year
77.47M
from 8.26M
Increased by 837.92%
Revenue Next Year
559.89M
from 77.47M
Increased by 622.70%
EPS This Year
-1.34
from -0.54
EPS Next Year
-1.27
from -1.34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|
| High | 326.8M | 1.2B | |||||
| Avg | 77.5M | 559.9M | |||||
| Low | 12.9M | 199.2M |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|
| High | 3,856.1% | 1,393.4% | |||||
| Avg | 837.9% | 622.7% | |||||
| Low | 55.7% | 157.1% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|
| High | -0.71 | -0.30 | |||||
| Avg | -1.34 | -1.27 | |||||
| Low | -1.84 | -1.86 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|
| High | - | - | |||||
| Avg | - | - | |||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.